Proteomic and transcriptomic analyses identify apo-transcobalamin-II as a biomarker of overall survival in osteosarcoma.
Lacinski RA, Dziadowicz SA, Roth CA, Ma L, Melemai VK, Fitzpatrick B, Chaharbakhshi E, Heim T, Lohse I, Schoedel KE, Hu G, Llosa NJ, Weiss KR, Lindsey BA.
Lacinski RA, et al. Among authors: fitzpatrick b.
Front Oncol. 2024 Oct 18;14:1417459. doi: 10.3389/fonc.2024.1417459. eCollection 2024.
Front Oncol. 2024.
PMID: 39493449
Free PMC article.